Welcome to our dedicated page for Surgery Partners news (Ticker: SGRY), a resource for investors and traders seeking the latest updates and insights on Surgery Partners stock.
Surgery Partners, Inc. (NASDAQ: SGRY) is a leading operator of surgical facilities and ancillary services across the United States, with more than 180 locations nationwide. The company is dedicated to providing exceptional integrated healthcare experiences for both providers and patients. Their diverse portfolio includes ambulatory surgery centers, surgical hospitals, multi-specialty physician practices, urgent care facilities, and a variety of ancillary services such as diagnostic laboratories, anesthesia services, optical services, and specialty pharmacy services.
Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners is one of the largest and fastest-growing surgical services businesses in the country. Their integrated outpatient delivery model focuses on providing high-quality, cost-effective solutions for surgical and related ancillary care. By leveraging an individualized, local market approach, they are able to offer flexible and tailored care solutions.
The company operates in two primary segments: Surgical Facility Services and Ancillary Services. The Surgical Facility Services segment accounts for the majority of their revenue, with their ancillary services supporting and enhancing their core surgical operations. This unique combination differentiates Surgery Partners from its competitors by offering a comprehensive suite of services under one roof.
In recent news, Surgery Partners reaffirmed its 2023 Adjusted EBITDA guidance of $436 million to $440 million and revenue guidance of approximately $2.75 billion. For 2024, they project an Adjusted EBITDA greater than $495 million, showcasing their commitment to mid-teens growth. Additionally, they have successfully executed multiple capital market transactions, enhancing their balance sheet and extending their debt maturities to 2030.
Recent achievements include targeted acquisitions, such as a specialty surgery hospital and other facilities, which are expected to contribute significantly to their growth. Surgery Partners continues to refine its operational execution, focusing on clinical quality, value, and physician recruiting. The company's strong pipeline and execution of key growth levers give them confidence in their future outlook.
Surgery Partners' financial condition remains robust, with cash and cash equivalents of $185.2 million and $607.3 million of borrowing capacity under its revolving credit facility as of March 31, 2024. The company’s first quarter of 2024 saw revenues increase by 7.7% to $717.4 million, and Adjusted EBITDA rose to $97.5 million.
For more detailed information and the latest updates, visit www.surgerypartners.com.
Surgery Partners (SGRY) reported a revenue increase of 15.9% to $707.1 million for Q4 2022 and 14.1% to $2.5 billion for the full year. Despite strong revenue growth, the company faced a net loss of $23.4 million for Q4 2022 and $54.6 million for the full year. Adjusted EBITDA rose by 5.6% to $120.8 million in Q4 and 12.0% to $380.2 million for the full year. The company anticipates 2023 revenues greater than $2.75 billion and Adjusted EBITDA exceeding $425 million.
Surgery Partners, Inc. (NASDAQ:SGRY) announced that it will release its fourth quarter 2022 results on March 1, 2023, before the market opens. A conference call will follow at 8:30 a.m. ET, where investors can access the live call by dialing 1-877-451-6152 for domestic calls and 1-201-389-0879 for international attendees. A replay will be available after the call until March 15, 2023. Surgery Partners is a prominent name in the healthcare sector, operating over 180 locations across 31 states. For more information, visit their website at www.surgerypartners.com.
Surgery Partners (NASDAQ:SGRY) is reaffirming its 2022 financial guidance during the J.P. Morgan Healthcare Conference on January 9, 2023. The company projects an Adjusted EBITDA of $375 million to $385 million and revenue of $2.50 billion to $2.55 billion. Headquartered in Brentwood, TN, Surgery Partners operates over 180 locations across 31 states, focusing on high-quality, cost-effective surgical services. The company acknowledges risks including COVID-19 impacts, economic conditions, and potential delays in financial closing procedures, which may affect actual results.
Surgery Partners, Inc. (NASDAQ:SGRY), a prominent healthcare services provider, will present at the J.P. Morgan Healthcare Conference on January 9, 2023, at 8:15 PM ET. Key executives, including Wayne S. DeVeydt, Eric Evans, and Dave Doherty, will engage with investors during this event. A live webcast of the presentation is accessible via the company’s Investor Relations website, with a replay available afterward. Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners operates over 180 locations across 31 states, delivering high-quality surgical and ancillary care.
Surgery Partners (NASDAQ:SGRY) reported third-quarter 2022 revenue of $620.6 million, a rise of 11.0% year-over-year. Same-facility revenues grew by 5.1%. Despite a net loss of $25.0 million, Adjusted EBITDA increased by nearly 26% to $96.2 million, with margins at 15.5%. The company reaffirmed its 2022 Adjusted EBITDA projection of $375 million to $385 million, and revenue expectations between $2.5 billion and $2.55 billion. The results were influenced by Hurricane Ian's impact on Florida operations, but strong operational performance and continued acquisitions helped maintain growth.
Surgery Partners, Inc. (NASDAQ:SGRY) announced that it will release its third quarter 2022 results before the market opens on November 8, 2022. This will be followed by a conference call at 8:30 a.m. Eastern Time. Interested participants can join the call via a domestic dial-in number at 1-877-451-6152 or an international line at 1-201-389-0879. A replay will be available shortly after the call until November 22, 2022. Surgery Partners operates over 180 surgical facilities across 32 states, focusing on cost-effective surgical solutions for patients and physicians.
Physicians Realty Trust reported a second quarter 2022 net income of $0.07 per share and $0.27 Normalized FFO per share, with total revenue rising 17% to $132.2 million. The Trust executed $46.9 million in investments, announced a quarterly dividend of $0.23 per share, and disposed of one property for $6.4 million, realizing a net gain of $3.7 million. A significant sale of three facilities in Great Falls, Montana on July 14 generated $116.3 million with a net gain of $53.9 million. The portfolio was 95% leased, and Same-Store Cash NOI grew 1.9% year-over-year.
Surgery Partners (NASDAQ:SGRY) reported a 13.3% revenue increase to $615.4 million for Q2 2022, driven by 149,000 surgical cases performed, up nearly 7% year-over-year. Adjusted EBITDA rose 13.4% to $86.1 million, with margins at 14.0%. Despite a net loss of $18.4 million, the company reaffirmed its 2022 guidance for revenue between $2.5 billion and $2.6 billion. Cash flow from operating activities surged to $42.1 million, significantly above last year's $2.3 million. The company maintains a strong liquidity position with $227.4 million in cash.
Surgery Partners (NASDAQ:SGRY) will announce its second quarter 2022 financial results on August 2, 2022, before market opening. A conference call is scheduled for 8:30 a.m. ET, where investors can join via a dedicated dial-in or webcast through the company’s Investor Relations website. Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners operates over 180 surgical facilities across 32 states, focusing on high-quality, cost-effective outpatient care.
Surgery Partners (NASDAQ:SGRY) will present at the Jefferies Healthcare Conference on June 8, 2022, at 4:30 p.m. EST. The event aims to connect the company with investors.
Interested parties can listen to a live webcast on the Surgery Partners investor relations page, with a replay available for a limited time thereafter.
Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners operates over 180 facilities in 32 states, focusing on high-quality, cost-effective surgical care.
FAQ
What is the current stock price of Surgery Partners (SGRY)?
What is the market cap of Surgery Partners (SGRY)?
What does Surgery Partners, Inc. do?
Where is Surgery Partners headquartered?
How many locations does Surgery Partners have?
What are the main revenue segments for Surgery Partners?
What recent financial guidance has Surgery Partners announced?
What recent acquisitions has Surgery Partners made?
What is Surgery Partners' approach to providing care?
How is Surgery Partners' financial condition?
Where can investors find more information about Surgery Partners?
What are the key growth drivers for Surgery Partners?
